RU2012104572A - DAPSON COMBINATION WITH ADAPALEN - Google Patents
DAPSON COMBINATION WITH ADAPALEN Download PDFInfo
- Publication number
- RU2012104572A RU2012104572A RU2012104572/15A RU2012104572A RU2012104572A RU 2012104572 A RU2012104572 A RU 2012104572A RU 2012104572/15 A RU2012104572/15 A RU 2012104572/15A RU 2012104572 A RU2012104572 A RU 2012104572A RU 2012104572 A RU2012104572 A RU 2012104572A
- Authority
- RU
- Russia
- Prior art keywords
- composition according
- dapsone
- dermatological
- adapalene
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
1. Дерматологическая композиция, включающая дапсон, адапален и воду.2. Дерматологическая композиция по п.1, отличающаяся тем, что включает 5% (в/в) дапсона и 0,1% (в/в) адапалена и применяется при лечении юношеских угрей.3. Дерматологическая композиция по п.2, отличающаяся тем, что включает 0,5% (в/в) дапсона и 0,3% (в/в) адапалена.4. Дерматологическая композиция по п.1, отличающаяся тем, что является гелем.5. Композиция по п.1, отличающаяся тем, что включает 0,5% (в/в) дапсона, 0,1% (в/в) адапалена, 1,5% (в/в) бензилового спирта, транскутола, 5-25% (в/в) ПЭГ-400, 0,01% (в/в) ЭДТА и 0,03% (в/в) лимонной кислоты.6. Композиция по п.5, отличающаяся тем, что дополнительно включает 1-4% (в/в) гидроксиэтилцеллюлозы.7. Композиция по п.5, отличающаяся тем, что дополнительно включает карбопол-980 в концентрации 0,5-2% (в/в).8. Композиция по п.5, отличающаяся тем, что дополнительно включает метилпарабен.9. Композиция по п.5, отличающаяся тем, что дополнительно включает молочную кислоту.10. Композиция по п.5, отличающаяся тем, что дополнительно включает глицерин.11. Композиция по п.5, отличающаяся тем, что дополнительно включает диметилизосорбид в концентрации 5-15% (в/в).12. Композиция по п.5, отличающаяся тем, что транскутол присутствует в количестве 25%.13. Композиция по п.5, отличающаяся тем, что для коррекции рН в нее добавлен буфер, содержащий NaOH, троламин и соляную кислоту.14. Композиция по п.13, отличающаяся тем, что рН равен 5,5.15. Композиция по п.5, отличающаяся тем, что дополнительно включает 2-3% гидроксиэтилцеллюлозы.16. Композиция по п.1, отличающаяся тем, что представлена водной из форм, выбираемых из группы, состоящей из геля, эмульсии, крема, жидкости, пасты, примочек, наноэмульсии, микроэмульсии1. Dermatological composition, including dapsone, adaptal and water. 2. Dermatological composition according to claim 1, characterized in that it comprises 5% (w / w) dapsone and 0.1% (w / w) adapalene and is used in the treatment of juvenile acne. Dermatological composition according to claim 2, characterized in that it comprises 0.5% (w / w) dapsone and 0.3% (w / w) adapalene. Dermatological composition according to claim 1, characterized in that it is a gel. The composition according to claim 1, characterized in that it comprises 0.5% (w / w) dapsone, 0.1% (w / w) adapalene, 1.5% (w / w) benzyl alcohol, transcutol, 5-25 % (w / w) PEG-400, 0.01% (w / w) EDTA and 0.03% (w / w) citric acid. 6. The composition according to claim 5, characterized in that it further comprises 1-4% (w / w) of hydroxyethyl cellulose. The composition according to claim 5, characterized in that it further comprises carbopol-980 at a concentration of 0.5-2% (w / w). The composition according to claim 5, characterized in that it further includes methyl paraben. The composition according to claim 5, characterized in that it further comprises lactic acid. The composition according to claim 5, characterized in that it further comprises glycerol. The composition according to claim 5, characterized in that it further comprises dimethyl isosorbide at a concentration of 5-15% (w / w). A composition according to claim 5, characterized in that transcutol is present in an amount of 25%. A composition according to claim 5, characterized in that a buffer containing NaOH, trolamine and hydrochloric acid is added to adjust the pH. The composition according to p. 13, characterized in that the pH is 5.5.15. The composition according to claim 5, characterized in that it further comprises 2-3% hydroxyethyl cellulose. The composition according to claim 1, characterized in that it is water from forms selected from the group consisting of a gel, emulsion, cream, liquid, paste, lotion, nanoemulsion, microemulsion
Claims (20)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22990309P | 2009-07-30 | 2009-07-30 | |
US61/229,903 | 2009-07-30 | ||
PCT/US2010/043671 WO2011014627A1 (en) | 2009-07-30 | 2010-07-29 | Combination of dapsone with adapalene |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2012104572A true RU2012104572A (en) | 2013-09-10 |
Family
ID=42953716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012104572/15A RU2012104572A (en) | 2009-07-30 | 2010-07-29 | DAPSON COMBINATION WITH ADAPALEN |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2459172A1 (en) |
JP (1) | JP2013500984A (en) |
AU (1) | AU2010278915A1 (en) |
CA (1) | CA2769640A1 (en) |
RU (1) | RU2012104572A (en) |
WO (1) | WO2011014627A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110117182A1 (en) * | 2009-07-30 | 2011-05-19 | Allergan, Inc. | Combination of dapsone with other anti-acne agents |
WO2011135090A1 (en) * | 2010-04-29 | 2011-11-03 | Galderma Research & Development | Method for treating scars with adapalene 0.3% |
JP2014506935A (en) * | 2011-03-03 | 2014-03-20 | アラーガン インコーポレイテッド | Silicone-based non-aqueous ophthalmic formulation |
RU2014102494A (en) | 2011-06-30 | 2015-08-10 | Аллерган, Инк. | RETINOID COMPOSITIONS FOR LOCAL USE AND METHODS FOR TREATING SKIN CONDITION |
HUE035940T2 (en) * | 2012-11-20 | 2018-05-28 | Allergan Inc | Topical dapsone and dapsone/adapalene compositions and methods for use thereof |
WO2016136925A1 (en) * | 2015-02-27 | 2016-09-01 | マルホ株式会社 | Composition for skin |
JP6508681B2 (en) * | 2016-01-18 | 2019-05-08 | 基嗣 田島 | Chemical peeling agent |
JP2020527607A (en) * | 2017-07-21 | 2020-09-10 | アルミラール・リミテッド・ライアビリティ・カンパニーAlmirall, Llc | Treatment of non-inflammatory lesions |
JPWO2019240290A1 (en) * | 2018-06-16 | 2021-06-24 | ロート製薬株式会社 | Topical composition |
JP7299766B2 (en) * | 2018-06-16 | 2023-06-28 | ロート製薬株式会社 | external composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030157036A1 (en) * | 2002-02-20 | 2003-08-21 | Osborne David W. | Topical dapsone for the treatment of acne |
KR20070091613A (en) * | 2004-11-08 | 2007-09-11 | 그렌마크 파머수티칼스 엘티디. | Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound |
MXPA06008988A (en) * | 2006-08-08 | 2008-02-07 | Fernando Ahumada Ayala | Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (miscrosponged benzoyl peroxide). |
US20100029781A1 (en) * | 2008-06-04 | 2010-02-04 | Morris Jerome A | Methods for preparation of anti-acne formulation and compositions prepared thereby |
-
2010
- 2010-07-29 CA CA2769640A patent/CA2769640A1/en not_active Abandoned
- 2010-07-29 RU RU2012104572/15A patent/RU2012104572A/en unknown
- 2010-07-29 AU AU2010278915A patent/AU2010278915A1/en not_active Abandoned
- 2010-07-29 JP JP2012523029A patent/JP2013500984A/en active Pending
- 2010-07-29 EP EP10744770A patent/EP2459172A1/en not_active Withdrawn
- 2010-07-29 WO PCT/US2010/043671 patent/WO2011014627A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2010278915A1 (en) | 2012-03-01 |
WO2011014627A1 (en) | 2011-02-03 |
CA2769640A1 (en) | 2011-02-03 |
JP2013500984A (en) | 2013-01-10 |
EP2459172A1 (en) | 2012-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2012104572A (en) | DAPSON COMBINATION WITH ADAPALEN | |
CN103239384B (en) | Grape seed compounded horse oil skin care product and preparation method thereof | |
WO2011007183A2 (en) | Skincare compositions | |
CN103520062B (en) | Facial cleanser containing peony essential oil and preparation method for facial cleanser | |
RU2010121989A (en) | COMPOSITION FOR LOCAL INTRODUCTION | |
GB2511350A (en) | Skincare compositions | |
EA201171079A1 (en) | FOAMING COMPOSITION FOR LOCAL APPLICATION | |
Singh et al. | The use of retinoids in the treatment of photoaging | |
US7883726B2 (en) | Skin care compositions with botanic seed oils | |
JP2018162325A (en) | Cosmetic compositions comprising marine plants | |
US8999356B1 (en) | Drug delivery system | |
WO2014155111A1 (en) | Skincare compositions | |
MXPA06013179A (en) | Anti acne skincare composition and skincare article. | |
CN101249095B (en) | Preparation of emulsifiable paste for containing decoloring agent, tretinoin and skinniness steroids | |
CN107281053A (en) | A kind of natural face cleaning admires silk | |
CA2614846C (en) | Acne treatment | |
UA101035C2 (en) | Emollient composition based on vaseline, glycerol, liquid paraffin | |
CN111514058A (en) | Skin whitening and brightening agent and preparation method thereof | |
JP2006508171A (en) | Topical compositions containing natural ingredients and methods of use | |
AU2011248152B2 (en) | Compositions comprising extracts of Southernwood and an amine compound | |
ITBS20010046A1 (en) | COMPOSITION FOR TOPICAL USE BASED ON THE ETHYL ESTER OF LINOLEIC ACID AND CITRIC ACID TRIETYL ESTER ASSOCIATED WITH OPPORT | |
PE20001567A1 (en) | RESORCINOL COMPOSITION | |
CN106619377A (en) | Aloe refreshing cleansing cream | |
KR102087655B1 (en) | Compositions containing an mixed components of dehydro-abietic acid and trans-communic acid for anti-aging | |
FR2995533A1 (en) | Cosmetic and/or dermatological composition, useful for treating acne and/or acne prone of skin, preventing and/or fighting against aging of skin, skin whitening and treating gressy skin, comprises Zygophyllum gaetulum extract, and carrier |